To further evaluate the molecular mechanism underlying the CDCA8-mediated HCC phenotype, we investigated mitogen-activated protein kinase (MAPK) pathway markers in CDCA8-knockdown and CDCA8 overexpression cells. This evidence concerns the gene WNK2 and hepatocellular carcinoma.